Nektar Therapeutics (NKTR) Misses Q4 EPS by 178c
Get Alerts NKTR Hot Sheet
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($1.78). Revenue for the quarter came in at $21.81 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EQT And KKKR Said Among Firms Considering Bids For Qiagen - Bloomberg
- Pinduoduo (PDD) Tops Q2 EPS by 98c
- Trump Sets Jan. 1, 2027 For 50% Canada Tariff Hike
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share